Millennium III Inc.

Millennium Initiates Phase II Trial for Diffuse Large B-Cell Lymphoma.
Heart Disease Weekly; 11/8/2009; 1898 words; Millennium: The Takeda Oncology...lymphoma (see also Millennium: The Takeda Oncology...Medical Officer, Millennium. "Millennium was...Pharmaceuticals, Inc. and Johnson & Johnson...from Phase II and III studies of single...

Following Stock Rise, OxiGene Private Placement Raises $15M.
BIOWORLD Today; 11/4/2009; 1189 words; ...one month ago, OxiGene Inc.'s stock sat below...week of May, Genentech Inc., of South San Francisco...exceeded" what the Phase III study was designed to...Avastin trial and news on Millennium Pharmaceuticals Inc.'s Velcade. Since...

Inex's NHL Drug Proves Strong In Final Phase II/III Study Data.
BIOWORLD Today; 11/4/2009; 1159 words; ...tested in the Phase II/III trial - a subset of which...the partial Phase II/III data at the time, Inex...year. In the Phase II/III trial, patients had failed...multiple myeloma from Millennium Pharmaceuticals Inc., of Cambridge, Mass...

Other News To Note.
BIOWORLD Today; 11/4/2009; 2211 words; AnorMED Inc., of Vancouver, British...months of therapy in a Phase III multicenter study of 98 patients...in Oviedo, Spain. Biogen Inc., of Cambridge, Mass...a nonexclusive license to Millennium Pharmaceuticals Inc., of Ca

Millennium's Velcade Entering Phase III For Multiple Myeloma.
BIOWORLD Today; 11/4/2009; 931 words; Staff Writer Millennium Pharmaceuticals Inc. initiated a Phase III trial of newly named Velcade...based Millennium said the Phase III trial will be a randomized, open...unavailable to discuss the Phase III trial launch, but said in a press...